OBJECTIVE-Insulin stimulates glucose uptake in skeletal muscle and adipose tissues primarily by stimulating the translocation of vesicles containing a facilitative glucose transporter, GLUT4, from intracellular compartments to the plasma membrane. The formation of stable soluble N-ethyl-maleimidesensitive fusion protein [NSF] attachment protein receptor (SNARE) complexes between vesicle-associated membrane protein-2 (VAMP-2) and syntaxin-4 initiates GLUT4 vesicle docking and fusion processes. Additional factors such as munc18c and tomosyn were reported to be negative regulators of the SNARE complex assembly involved in GLUT4 vesicle fusion. However, despite numerous investigations, the positive regulators have not been adequately clarified.
I
nsulin stimulates glucose uptake in skeletal muscles and adipose tissues primarily by stimulating the translocation of vesicles containing a facilitative glucose transporter, GLUT4, from intracellular compartments to the plasma membrane (1, 2) . In addition to this translocation step, membrane fusion processes are also controlled by insulin (3, 4) . Like other regulated exocytotic processes in many cell types, the formation of stable soluble N-ethyl-maleimide-sensitive fusion protein [NSF] attachment protein receptor (SNARE) complexes between vesicle-associated membrane protein-2 (VAMP-2) and syntaxin-4 initiates GLUT4 vesicle docking and fusion processes (5) . However, the precise mechanism by which insulin regulates SNARE complex assembly remains poorly understood.
In neurons, Ca 2ϩ triggers exocytotic membrane fusion of synaptic vesicles to the plasma membrane, and calcium sensor proteins such as synaptotagmins have critical roles in this process (6, 7) . Similar mechanisms result in GLUT4 vesicle fusion in adipocytes and muscle cells. Whitehead et al. (8) demonstrated, and we confirmed, that reduction of intracellular Ca 2ϩ ([Ca 2ϩ ] i ) using the membrane-permeable Ca 2ϩ -chelating agent BAPTA-AM diminished insulinstimulated glucose transport, whereas this reagent did not inhibit GLUT4 translocation to the plasma membrane (i.e., GLUT4 vesicle trafficking was not impaired) (8) (N.F., M.E., unpublished observation). These observations suggest that an appropriate intracellular Ca 2ϩ level may be required for the final docking/fusion steps of GLUT4 vesicles in adipocytes.
The universal role of Ca 2ϩ as a trigger for regulated exocytosis predicts the existence of conserved proteins capable of activating the fusion machinery upon binding Ca 2ϩ . Although many proteins have been suggested to play such a role, synaptotagmins have attracted the most attention as putative calcium sensor proteins functioning in regulated exocytosis (9) . Synaptotagmin family proteins have tandem C2 domains at the C-terminus. These two domains, C2A and C2B, are conserved in all 13 synaptotagmins described to date and constitute Ca 2ϩ -binding modules (10) . Many proteins have been identified as being involved in the GLUT4 vesicle fusion machinery in adipocytes. However, neither synaptotagmins nor other calcium sensor proteins have as yet been reported to regulate GLUT4 vesicle fusion.
We investigated, in detail, the mechanisms of Ca 2ϩ -dependent GLUT4 vesicle fusion in adipocytes. We searched for double C2 domain proteins as candidate Ca 2ϩ sensor proteins suitable for the relatively slow (on the order of several minutes) SNARE complex formation, and we found that DOC2b bound syntaxin-4 upon insulin stimulation in an intracellular Ca 2ϩ -dependent manner and mediated GLUT4 vesicle fusion. DOC2b may be a downstream target of the insulin signal and a positive regulator of SNARE assembly involving regulated exocytosis in adipocytes.
RESEARCH DESIGN AND METHODS
Mouse DOC2a and DOC2b cDNA constructs were kindly provided by Dr. R.R. Duncan (University of Edinburgh, Edinburgh, U.K.). Mouse munc18c cDNA construct was kindly provided by Dr. T. Takuma (School of Dentistry, Health Sciences University of Hokkaido, Hokkaido, Japan). Cell culture. 3T3-L1 fibroblasts were grown in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS) at 37°C. The cells (3-5 days after confluence) differentiated into adipocytes with incubation in the same DMEM, containing 0.5 mmol/l isobutylmethylxanthine, 0.25 mol/l dexamethasone, and 4 g/ml insulin, for 3 days and were then grown in DMEM with 10% FBS for an additional 5-8 days.
Plasmids and antibodies. Wild-type DOC2b was subcloned into peGFP-C2, pDsRed2-C1 (Clontech, Palo Alto, CA), and pGEX-6P1 (GH Healthcare, Buckinghamshire, U.K.) vectors. Calcium interacting domain mutants (CIMs) of DOC2b (D157N, D163N, D297N , and D303N) were subcloned into peGFP-C2 and pGEX-6P1 vectors. We also constructed syntaxin-4 and a series of deletion mutants of DOC2b corresponding to ⌬munc13 interaction domain (MID) (amino acids 36 -413), ⌬C2A (2-120 and 252-413), and ⌬C2B (2-264) in a peGFP-C2 vector. Myc-tagged DOC2b (wild-type or CIM) was subcloned into a pcDNA3 vector. All chemically synthesized and PCR-derived DNA sequences were verified by DNA sequencing. Rabbit polyclonal DOC2b antibody was generated against the peptide sequence CGARDDDEDVDQL specific for DOC2b isoform. This antibody was found to cross-react minimally (online appendix Fig. S1 [available at http:// dx.doi.org/10.2337/db08-0303). The following antibodies were used: monoclonal anti-GLUT4 (clone 1F8) (R&D systems, Minneapolis, MN), polyclonal anti-GLUT4, anti-GST (Santa Cruz Biotechnology, Santa Cruz, CA), anti-myc (clone 9E10) (Covance, Princeton, NJ), polyclonal anti-syntaxin-4 (Synaptic Systems, Gottingen, Germany), and fluorescent-conjugated and horseradish peroxidase-conjugated secondary antibodies (Jackson Immuno Research, West Grove, PA). DOC2b shRNA construct. Short-hairpin RNA (shRNA) specific for mouse DOC2b was designed to have a 5Ј-GCCAGATGTAGACAAGAAATC-3Ј sequence. Synthetic complementary single-stranded DNA of the target sequence was annealed, and the double-stranded DNA was inserted into a pcPURϩU6i cassette (11) . This shRNA decreased DOC2b protein expression to 10 -20% of the control level within 74 h. A same cassette encoding nonspecific scramble sequence was used as a negative control. Preparation of recombinant adenovirus vectors. Adenovirus producing enhanced green fluorescent protein (eGFP), myc-tagged DOC2b (wild type, CIM mutant), and shRNA (DOC2b, control) were prepared using an AdEasy adenovirus vector system according to the manufacturer's instructions (Stratagene, Cedar Creek, TX). All amplified viruses were purified by the cesium chloride centrifugation method and stored at Ϫ80°C. Live cell imaging of DOC2b. The peGFP-DOC2b was electroporated into 3T3-L1 adipocytes, which were then reseeded onto 0.1-mm glass-bottom dishes (Matsunami, Tokyo, Japan). At 24 -48 h after electroporation, cells were serum starved for 3-4 h in DMEM and then incubated at 37°C for 2 h in Krebs-Ringer HEPES buffer (130 mmol/l NaCl, 5 mmol/l KCl, 1.3 mmol/l CaCl 2 , 1.3 mmol/l MgSO 4 , 25 mmol/l HEPES [pH 7.4]). The cells were treated with 100 nmol/l of insulin at 37°C for the time indicated and observed by laser confocal microscopy (LSM510 Pascal; Carl Zeiss, Oberkochen, Germany). For the translocation analysis, fluorescent intensities at three distinct areas in plasma membrane, cytosol, and nucleus (nine areas per cell each) of three independent cells were analyzed by Photoshop software CS2. Yeast two-hybrid screening. The Matchmaker Yeast Two-Hybrid System (Clontech) was used for determination of DOC2b-binding partners. Full-length DOC2b and munc18c cDNA were subcloned into a pLexA vector and full-length syntaxin-4 and munc18c cDNA into a pB42AD vector. A standard lithium acetate/single-stranded carrier DNA/polyethylene glycol method for transformation into yeast strain EGY48 (p8op-lacZ) was used, and these proteins were expressed in this strain. Transcriptional activation of LacZ was determined by an X-Gal assay. ␤-Galactosidase activity was detected within 16 h of reaction at 30°C. In vitro GST pull-down assay. Glutathione S-transferase (GST) fusion proteins of wild-type and CIM DOC2b were purified according to the manufacturer's instructions. GST syntaxin-4 was cleaved with PreScission Protease (2 units/l) (GH Healthcare) in buffer containing 50 mmol/l Tris-HCl (pH 7.0), 150 mmol/l NaCl, 1 mmol/l EDTA, and 1 mmol/l dithiothreitol at 4°C for 16 h.
At the end of incubation, cleaved syntaxin-4 protein was further purified using Amicon Ultra filter devices (Millipore, Danvers, MA).
Recombinant individual GST-DOC2bs or GST (1 g each) were incubated with 1 g of recombinant syntaxin-4 in 1 ml of Tris-buffered saline (20 mmol/l Tris, pH 7.4, 150 mmol/l NaCl) plus 0.5% Triton X-100 in the presence of 2 mmol/l EDTA or 1 mmol/l CaCl 2 for 4 -6 h. This mixture was immunoprecipitated by incubating with Glutathion Sepharose 4B (GE Healthcare) for 1 h. The precipitates were washed four times and analyzed by SDS-PAGE and immunoblotting. Approximately 5% of syntaxin-4 was pulled down by the GST-DOC2b. Northern blotting. Total RNAs were prepared from 3T3-L1 fibroblasts, 3T3-L1 adipocytes (days 3 and 9 of differentiation) or rat epididymal fat, and mouse brain using ISOGEN (Nippongene, Tokyo, Japan) and denatured in formaldehyde/formamide, resolved by electrophoresis, and transferred to hybond-N membranes (GH Healthcare). The membranes were hybridized with ␣-[
32 P]-labeled full-length DOC2a and DOC2b cDNAs as probes and then washed three times with 1ϫ saline sodium citrate buffer (15 mmol/l NaCl, 15 mmol/l sodium citrate [pH 7.0], and 0.1% SDS) at 65°C. Radioisotopic measurements were conducted using a Phosphorimager FLA2000 (Fuji film, Tokyo, Japan). Immunoprecipitation and immunoblotting. A 10-cm plate of cells was lysed in 1 ml of lysis buffer (20 mmol/l HEPES [pH 7.2], 100 mmol/l NaCl, 25 mmol/l NaF, 1 mmol/l sodium vanadate, 1 mmol/l benzamidine, 5 g/ml leupeptin, 5 g/ml aprotinin, 1 mmol/l phenylmethylsulphonyl fluoride, 1 mmol/l dithiothreitol, and 0.5% NP-40) in the presence of 2 mmol/l EDTA or 1 mmol/l CaCl 2 and centrifuged for 15 min at 15,000g. The postnuclear lysates were used for the following experiments. The protein concentration was measured with a bicinchoninic acid protein assay reagent (Pierce, IL). For immunoprecipitation, the cell lysates were preincubated with protein-G/ASepharose at 4°C for 30 min to remove nonspecific bound proteins. Then, samples were incubated with primary antibodies at 4°C for 8 -12 h followed by incubation with protein-G/A-Sepharose. Lysates and immunoprecipitates were resolved by SDS-PAGE and transferred to a polyvinylidene fluoride membrane (GH Healthcare). The membranes were incubated with primary antibodies for 8 -12 h. Protein signals were visualized using horseradish peroxidase-conjugated secondary antibodies and an enhanced chemiluminescence substrate kit (GH Healthcare). The efficiencies of immunoprecipitation of the associated protein in Fig. 3C -E were ϳ1, 0.5, and 0.6%, respectively. All the images in figures are representative, and we repeated the immunoblots at least three times and found similar results. Immunofluorescence microscopy and digital image analysis. Differentiated 3T3-L1 adipocytes were left untreated or electroporated by eGFP-DOC2b (wild type, CIM, ⌬MID, ⌬C2A, and ⌬C2B), eGFP alone, DsRed2-DOC2b (wild type, CIM), shRNAs (control, DOC2b), or myc-GLUT4-eGFP. The cells were then replated onto coverslips and allowed to recover for 48 h. Cells were preincubated in the presence or absence of 50 mol/l of BAPTA-AM for 10 min, followed by incubation with or without insulin for 20 min at 37°C. Next, the cells were fixed with 3.7% formaldehyde in PBS and permeabilized with buffer A (0.5% Triton X-100, 1% FBS in PBS) for 15 min. For the detection of endogenous proteins, the coverslips were incubated for 2 h with primary antibodies at room temperature. The cells were washed and incubated with an appropriate secondary antibody for 30 min. The coverslips were washed thoroughly again and mounted on glass slides. Immunostained cells were observed at room temperature with an LSM 5 PASCAL laser-scanning confocal microscope and its two-channel-scanning module (Carl Zeiss) equipped with an inverted Zeiss Axiovert 200M using the 63ϫ oil objective lens (numerical aperture 1.4) run by LSM 5 processing software and Adobe Photoshop CS2. At least five cells were observed in a condition. The experiments were repeated at least three times, unless stated otherwise. All the images in figures are representative, and the conclusions are based on qualitative visual impression. The cell surface myc-GLUT4-eGFP was measured by subtracting the internal myc signal from total myc signal of electroporated cells. The plasma membrane eGFP content was also measured. The cell surface GLUT4 was calculated as (total myc Ϫ internal myc)/(total eGFP Ϫ internal eGFP) (22) . 2-Deoxy-glucose uptake. Differentiated adipocytes were prepared in 24-well plates. Cells were infected with the recombinant adenoviruses. Two days thereafter, the cells were serum starved for 2 h at 37°C in Krebs-Ringer HEPES buffer. Then, the cells were stimulated with or without 100 nmol/l of insulin for 10 min, and 2-deoxy-glucose uptake was determined by 2-deoxy-D-[2,6 3 H] glucose incorporation. Nonspecific glucose uptake was measured in the presence of 20 mol/l cytochalasin B and subtracted from each determination to obtain specific uptake. The results were normalized by the protein amount. Statistical analysis. Multiple comparisons among groups were performed using one-way ANOVA (post hoc test: Tukey-Kramer). Results are presented as means Ϯ SD. Values of P Ͻ 0.05 were considered statistically significant.
DOC2b REGULATES GLUT4 VESICLE FUSION

RESULTS
DOC2b
translocates to the plasma membrane in response to insulin. Type C tandem C2 domain proteins are classified into three groups (i.e., synaptotagmin and synaptotagmin-like protein and DOC2 family proteins). The first two groups of proteins regulate relatively fast membrane fusion (on the order of milliseconds to a few seconds) (12, 13) . This time scale is not suitable for GLUT4 vesicle fusion. Therefore, we focused on DOC2 family proteins as candidate regulators of GLUT4 vesicle fusion. First, we determined the expression profile of DOC2 mRNA in adipocytes. As shown in Fig. 1A , DOC2a was not expressed in 3T3-L1 adipocytes. According to a previous study, DOC2␥ is localized to the nucleus and has no Ca 2ϩ -binding activity because of amino acid substitutions at the Ca 2ϩ -binding sites (14) . Thus, we investigated the function of the DOC2b isoform involved in GLUT4 membrane fusion. Next, we examined the intracellular localization of DOC2b in differentiated 3T3-L1 adipocytes using anti-DOC2b antibody (Fig. 1B) or by expressing an eGFP fused to DOC2b (Fig. 2A) . As shown in Fig. 1B , DOC2b results in a fine punctate or granular appearance throughout the cytoplasm under basal conditions. In contrast, the addition of insulin yields relatively slow (ϳ5 min) translocation of DOC2b to the cell periphery ( Fig. 2A) . This time scale of translocation was very similar to that of GLUT4 vesicles. It is noteworthy that deletion of the MID enhanced plasma membrane localization even in the absence of insulin and that the C2B domain is necessary for membrane targeting (Fig. 2B ). These observations are interesting in considering the distinct roles of the C2A and C2B domains and the negative regulatory function of MID. We performed additional experiments to determine the role of calcium in the translocation of DOC2b. As shown in Fig. 2C , the cell membrane permeable Ca 2ϩ -chelating agent BAPTA-AM inhibited insulin-dependent translocation of DOC2b. DOC2b binds syntaxin-4 upon stimulation with insulin. Since DOC2b is thought to be a soluble calciumsensing protein, compartment-specific targeting must be achieved through interaction with membrane-bound proteins such as SNARE and SNARE-related proteins. Therefore, we attempted to identify DOC2b-binding partners among these proteins using a yeast two-hybrid system. We found a very strong interaction between DOC2b and syntaxin-4 compared with the already known binding between munc18c and syntaxin4 (Fig. 3A) . Interestingly, this t-SNARE protein is reportedly a key molecule for GLUT4 vesicle fusion in response to insulin (5, 15) . Although this interaction was very strong, SNARE proteins are quite "sticky" and can on occasion bind with many proteins nonspecifically. Therefore, we performed the following three additional experiments. First, we determined the direct interaction in vitro using recombinant proteins, GST-tagged DOC2b, and synthesized syntaxin-4. As shown in Fig. 3B , the interaction was easily detected by immunoblotting in the presence of calcium. Second, we examined endogenous protein-protein interactions by immunoprecipitation experiments using polyclonal antiDOC2b. As shown in Fig. 3C , insulin treatment increased DOC2b-syntaxin-4 binding, and BAPTA-AM abolished this interaction. Since the molecular weights of DOC2b and the IgG heavy chain are quite similar (computed molecular weight of DOC2b and syntaxin-4 are 46 and 34 kDa, respectively), it was difficult to perform a reverse immunoprecipitation experiment. Third, our results were confirmed by immunoprecipitation experiments using adipocytes expressing myc-tagged DOC2b ( Fig. 3D and E) . It is important to note that we could not detect the interaction between DOC2b and syntaxin-4 in the buffer containing EDTA (data not shown). Furthermore, we could not find interaction between DOC2b and syntaxin6 in 3T3-L1 adipocytes (online appendix Fig. S2 ).
To better assess the calcium dependency of DOC2b translocation and interaction with syntaxin-4 in adipocytes, we conducted the following additional experiments using a Ca 2ϩ -unbound mutant. Based on the information from crystallographic analysis of synaptotagmin-1 (16 -18), we created mutations in the putative Ca 2ϩ -binding sites of DOC2b (i.e., C2A [D157N, D163N] and C2B [D297N, D303N]) and designated the product obtained the CIM (Fig. 4A ). This type of mutant reportedly loses its calcium-dependent phospholipids-targeting capacity (19, 20) . As shown in Fig. 4B , the CIM mutation markedly inhibited insulin-induced DOC2b translocation. Furthermore, CIMDOC2b also failed to interact with syntaxin-4 in both the in vivo and the in vitro setting (Fig. 4C-E) . These results raise the possibility that Ca 2ϩ binding is essential for insulin-stimulated DOC2b translocation as well as the interaction with syntaxin-4. 
DOC2b REGULATES GLUT4 VESICLE FUSION
DOC2b regulates the step of GLUT4 vesicle fusion in response to insulin. One interpretation of the above findings is that DOC2b may act as a Ca 2ϩ sensor protein for SNARE complexes triggering GLUT4 vesicle fusion. To assess the role of DOC2b in GLUT4 vesicle fusion to the plasma membrane, we utilized a GLUT4 construct containing four myc epitopes in the first exofacial loop of GLUT4 and an eGFP fusion at its cytoplasmic COOH terminus. These exofacial tags are easily detected by anti-myc antibody but only when GLUT4 vesicles are fused to the plasma membrane (21) . Adipocytes expressing this GLUT4 construct and DsRed2-DOC2b (wild type or CIM) or shRNAs were observed by confocal microscopy. As shown in Fig. 5A and B, the externalized GLUT4 was increased in the cells coexpressing wild-type DOC2b, while being decreased in those coexpressing CIM-DOC2b or shRNA (shRNA DOC2b ) compared with the control cells. Since the above conclusions were based on qualitative visual impression, we next estimated the fluorescent signals of the cellular rims in Fig. 5A and B in two ways. First, we counted the number of the cells with eGFP rims (50 cells in each condition) in the cells expressing myc-GLUT4-eGFP. As shown in Fig. 5C , just translocated or docked GLUT4 detected by eGFP fluorescence did not change under either condition. Second, we quantified the ratio of cell surface GLUT4 (myc sinal) to GLUT4 translocated to plasma membrane (eGFP signal) as previously described (22) . As shown in Fig. 5D and E, cell surface GLUT4 was increased in the cells expressing wild-type DOC2b but decreased in those expressing CIM-DOC2b and silenced DOC2b (Fig. 5D and E) . These results, taken together with the data shown in Fig. 5A , are consistent with the idea that DOC2b is a calcium-sensing protein and regulates the GLUT4 vesicle fusion step in response to insulin. Role of DOC2b in glucose transport in 3T3-L1 adipocytes. We next focused on the role of DOC2b in insulin-dependent glucose uptake in adipocytes expressing wild-type DOC2b and CIM-DOC2b. As shown in Fig.  6A , overexpression of wild-type DOC2b increased insulinstimulated glucose uptake to 122% of the control level. In contrast, overexpression of CIM-DOC2b decreased to 78% of the control level. Furthermore, we introduced shRNAs (shRNA DOC2b, control ) by adenovirus vectors into cultured adipocytes to induce specific degradation of the DOC2b mRNA. DOC2b protein expression was decreased to 50 and 10% of the control level in the cells infected with viruses at multiplicity of infection (MOI) of 20 and 50, respectively (Fig. 6B) . As expected, glucose uptake was decreased from 87 to 60% in adipocytes infected with the adenovirus vectors at MOI of 20 -50 (Fig. 6B) . To confirm the specificity of silencing, we conducted add-back style rescue experiment using adenovirus vector containing wild-type DOC2b. As shown in online appendix Fig. S3 , overexpression of DOC2b rescued the inhibitory effect on glucose uptake in DOC2b-silenced cells. Under these conditions, DOC2b overexpression and silencing had no effects on serine phosphorylation of Akt (Fig. 6A and B and online appendix Fig. S3 ). These results, taken together with the data presented in Figs. 2-5 , suggest that DOC2b regulates glucose transport through modulating vesicle fusion processes but not insulin signaling.
DISCUSSION
Regulation of glucose uptake in muscle and adipose tissues by insulin is of fundamental importance for proper maintenance of postprandial hyperglycemia. This hormone stimulates translocation of the GLUT4 glucose transporter from the intracellular membrane to the cell surface (1, 2) . In addition to this movement of intracellular vesicles containing GLUT4, it has been suggested that the docking and fusion step of GLUT4 vesicles is also critically regulated by insulin (3, 4, 23) . However, the precise mechanism by which insulin regulates vesicle fusion is still largely unknown.
A key finding of this study is identification of the double C2 domain protein DOC2b, which mediates insulin-regulated GLUT4 vesicle fusion. Like other membrane fusion processes, GLUT4 vesicle fusion occurs essentially through the formation of a "core complex" consisting of syntaxin-4 and VAMP-2 (5). In general, however, a number of additional factors are required to bring about SNAREmediated membrane fusion in vivo. Many of these factors,
PPT. D157N, D163N, D297N, and D303N) which can collectively be called SNARE regulators (e.g., munc18, synaptotagmin, munc13, GATE-16/Apg8, LMA1, synaptophysin, tomosyn, and Vsm1/Ddi1), bind directly to SNARE proteins and are involved in membrane trafficking and fusion events (24) . Among these SNARE regulators, munc18c and tomosyn were reported to be negative regulators of the SNARE complex assembly involved in GLUT4 vesicle fusion (25) (26) (27) . Despite numerous investigations, the positive SNARE regulators for GLUT4 vesicle fusion have not been adequately clarified. In this report, we have shown that 
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DOC2b mediates insulin-stimulated GLUT4 membrane fusion in adipocytes, while having no effect on the GLUT4 vesicle translocation step. These data are consistent with the hypothesis that DOC2b regulates insulin-stimulated GLUT4 vesicle fusion. DOC2b may be a positive SNARE regulator for vesicle fusion processes in adipocytes.
A second significant finding reported herein is the identification of a DOC2b binding partner. DOC2b interacts with t-SNARE syntaxin-4 upon stimulation with insulin in the presence of calcium. Syntaxin-4 is thought to be a SNARE protein on the target membrane for GLUT4 vesicle fusion (28, 29) . As shown in Fig. 3A , this interaction appears to be very strong compared with that between munc18c and syntaxin-4 demonstrated by the yeast two-hybrid method. Although this interaction appeared to be very strong, SNARE proteins are quite sticky and can on occasion bind with many proteins nonspecifically. Therefore, we performed three additional experiments. As shown in Fig. 3B -E, we confirmed the interaction between DOC2b and syntaxin-4 in both the in vivo and the in vitro setting. Furthermore, changes in the intracellular localization of DOC2b also supported the functional interaction. As shown in Fig. 2A, DOC2b translocates to the plasma membrane in response to insulin stimulation. Importantly, the time scale of DOC2b translocation coincides with relatively slow externalization of GLUT4 vesicles. Taken together, our data are consistent with the aforementioned hypothesis that DOC2b regulates GLUT4 vesicle fusion by triggering SNARE complex assembly.
Another interesting observation made in this study is the essential role of [Ca 2ϩ ]i in insulin-stimulated GLUT4 vesicle fusion. In 2001, Whitehead et al. (8) first reported that a calcium chelator, BAPTA-AM, inhibited GLUT4 externalization and glucose uptake. However, the precise mechanism underlying calcium-dependent GLUT4 vesicle fusion remains unknown because no studies have as yet focused on Ca 2ϩ -sensing proteins in adipocytes. DOC2b is structurally similar to the well-known calcium-sensing SNARE regulator synaptotagmins (Fig. 4A ). Taking these observations together, we hypothesized that DOC2b is a Ca 2ϩ -sensing protein that regulates GLUT4 vesicle fusion in adipocytes. To better assess the role of Ca 2ϩ in GLUT4 vesicle fusion, we confirmed the following. First, DOC2b translocation and its binding to syntaxin-4 were shown to be [Ca 2ϩ ]i dependent. Second, mutations in calcium-binding sites on C2 domains of DOC2b resulted in loss of syntaxin-4 binding, GLUT4 externalization, and glucose uptake. In contrast, we also observed DOC2b-syntaxin-4 binding, without insulin action, in a GST pull-down assay, suggesting that [Ca 2ϩ ]i is necessary for this interaction in vitro (Fig. 3B) . In parallel, we also found that insulin initiates the DOC2b translocation to plasma membrane and promotes interaction between DOC2b and syntaxin-4 in the presence of Ca 2ϩ ions. Based on the above observations, we propose a simple model whereby insulin regulates SNARE regulator DOC2b, and basal level of [Ca 2ϩ ]i may act in a constitutive manner to promote DOC2b-syntaxin-4 interaction involved in insulin-stimulated GLUT4 vesicle fusion.
A recent report (30) suggests that DOC2 proteins remove munc18 from syntaxin, thereby regulating core SNARE complex formation. This interpretation is very attractive because munc18c is thought to be a negative regulator of GLUT4 vesicle fusion. Although we have no direct data pertaining to munc18c, it is possible that munc18c and DOC2b may modulate SNARE assembly in a counterregulatory manner. Very recently, Ke et al. (31) reported that DOC2b bound munc18c, but not syntaxin-4, in pancreatic ␤-cells. This apparent discrepancy on syntaxin-4 binding may be attributable to the different experimental conditions. They performed most of their experiments using a buffer without calcium (i.e., Nonidet P-40 lysis buffer). Since DOC2b has conserved Ca 2ϩ -binding sites and is thought to be a Ca 2ϩ sensor protein in other cell types such as neuron (32) and chromaffin cells (33) , Ca 2ϩ might be important for the physiological properties of DOC2b in ␤-cells. Further work is required to uncover the underling mechanisms by which DOC2b regulates SNARE assembly in response to insulin.
In summary, we have identified DOC2b as a syntaxin-4 binding protein in adipocytes. This protein regulates GLUT4 vesicle fusion as well as glucose uptake in response to insulin stimulation. We have further revealed that DOC2b requires [Ca 2ϩ ]i and positively regulates the step of GLUT4 vesicle fusion.
